A detailed history of Two Sigma Investments, LP transactions in Liquidia Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 314,103 shares of LQDA stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
314,103
Previous 346,125 9.25%
Holding current value
$3.09 Million
Previous $4.15 Million 24.37%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.9 - $14.11 $284,995 - $451,830
-32,022 Reduced 9.25%
314,103 $3.14 Million
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $637,109 - $836,871
53,270 Added 18.19%
346,125 $4.15 Million
Q1 2024

May 15, 2024

SELL
$11.35 - $16.73 $663,521 - $978,035
-58,460 Reduced 16.64%
292,855 $4.32 Million
Q4 2023

Feb 14, 2024

BUY
$5.77 - $12.19 $509,866 - $1.08 Million
88,365 Added 33.61%
351,315 $4.23 Million
Q3 2023

Nov 14, 2023

SELL
$6.27 - $8.15 $395,705 - $514,354
-63,111 Reduced 19.36%
262,950 $1.67 Million
Q2 2023

Aug 14, 2023

SELL
$6.63 - $9.9 $359,942 - $537,471
-54,290 Reduced 14.27%
326,061 $2.56 Million
Q1 2023

May 15, 2023

SELL
$5.72 - $7.91 $655,637 - $906,660
-114,622 Reduced 23.16%
380,351 $2.63 Million
Q4 2022

Feb 14, 2023

SELL
$4.68 - $6.54 $1.62 Million - $2.26 Million
-345,643 Reduced 41.12%
494,973 $3.15 Million
Q3 2022

Nov 14, 2022

BUY
$3.73 - $8.39 $1.25 Million - $2.81 Million
334,997 Added 66.25%
840,616 $4.57 Million
Q2 2022

Aug 15, 2022

BUY
$3.37 - $7.55 $471,931 - $1.06 Million
140,039 Added 38.31%
505,619 $2.2 Million
Q1 2022

May 16, 2022

SELL
$5.14 - $7.38 $242,171 - $347,708
-47,115 Reduced 11.42%
365,580 $2.63 Million
Q4 2021

Feb 14, 2022

BUY
$2.71 - $5.17 $972,705 - $1.86 Million
358,932 Added 667.62%
412,695 $2.01 Million
Q3 2021

Nov 15, 2021

BUY
$2.28 - $2.95 $28,643 - $37,060
12,563 Added 30.49%
53,763 $148,000
Q2 2021

Aug 16, 2021

BUY
$2.51 - $3.11 $103,411 - $128,132
41,200 New
41,200 $118,000
Q4 2020

Feb 16, 2021

SELL
$2.6 - $5.79 $500,921 - $1.12 Million
-192,662 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.34 - $8.28 $231,395 - $441,464
53,317 Added 38.26%
192,662 $948,000
Q2 2020

Aug 14, 2020

BUY
$4.86 - $11.44 $677,216 - $1.59 Million
139,345 New
139,345 $1.17 Million
Q1 2020

May 15, 2020

SELL
$3.31 - $7.15 $78,380 - $169,312
-23,680 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.07 - $5.11 $6,324 - $10,526
2,060 Added 9.53%
23,680 $101,000
Q3 2019

Nov 14, 2019

SELL
$3.29 - $8.24 $77,696 - $194,595
-23,616 Reduced 52.21%
21,620 $77,000
Q2 2019

Aug 14, 2019

BUY
$7.92 - $11.39 $358,269 - $515,238
45,236 New
45,236 $362,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $633M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.